patent 6,126,967 filed September 3, 1998 was granted for "Extended release acetaminophen particles." Structure and reactivity Paracetamol consists of a benzene ring core, substituted by one hydroxyl group and the nitrogen atom of an amide group in the para (1,4) pattern
In the LURIC study, a single cut-off point (0.8 fmol/ml) of Big-ET-1 was significantly associated with higher incidence rates of cardiovascular death at both intermediate and high NT-proBNP levels.96 In a post hoc analysis of the RELAX trial, plasma ET-1 levels were significantly associated with lower exercise oxygen consumption both at baseline and longitudinally over 24 weeks.97 ET-1 levels were predictive of 1-year HF hospitalisation and were associated with long-term mortality in HFpEF patients ( Table 2 ), suggesting that ET-1 could be a biomarker in HFpEF and a potential therapeutic target.98 Following this, in a prospective study with HFpEF patients, the dual ET-A/ET-B receptor inhibitor macitentan improved HFpEF by abrogating adverse cardiac remodelling via antihypertrophic mechanisms and by reducing stiffness.99 In the same population, sitaxsentan, a selective ET-A receptor antagonist, increased exercise tolerance but did not improve any of the secondary endpoints such as LV mass or diastolic function.100 Plasminogen Activator Inhibitor-1 Plasminogen activator inhibitor-1 (PAI-1) is a serine protease inhibitor that functions as the principal inhibitor of tissue plasminogen activator and urokinase, the activators of plasminogen and hence fibrinolysis
In China, Trulicity (dulaglutide) was approved in February 2019 and officially launched in June 2019
Semaglutide works by mimicking a natural hormone called GLP-1
